O Opus Genetics, Inc.: management transactions · United States · SEC (Form 4) Browse the full insider trade history of Opus Genetics, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 6 May 2025 (C). Among the most active insiders: Magrath George. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 6 May 2025
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
● Director · Executives · 5 May 2025
6,927,419 shares Common Stock SEC:0001578563-25-000238:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001424:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001429:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001428:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001425:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001430:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001427:0
◆ Director · Executives · 30 Apr 2025
79,504 shares 0Common Stock SEC:0000905148-25-001426:0
◆ Chief Executive Officer · Executives · 24 Mar 2025
392,157 shares Common Stock SEC:0000905148-25-001007:0
◆ Director · Executives · 24 Mar 2025
784,314 shares Common Stock SEC:0000905148-25-001006:0
◆ SVP of Corp. Dev. · Executives · 13 Mar 2025
29,500 shares 0Common Stock SEC:0000905148-25-000937:0
◆ Chief Operating Officer · Executives · 13 Mar 2025
52,500 shares 0Common Stock SEC:0000905148-25-000942:0
◆ Chief Financial Officer · Executives · 13 Mar 2025
52,500 shares 0Common Stock SEC:0000905148-25-000939:0
◆ Chief Executive Officer · Executives · 13 Mar 2025
330,697 shares 0Common Stock SEC:0000905148-25-000940:0
◆ SVP of Finance · Executives · 13 Mar 2025
39,500 shares 0Common Stock SEC:0000905148-25-000941:0
◆ Chief Scientific & Dev. Ofc. · Executives · 13 Mar 2025
52,500 shares 0Common Stock SEC:0000905148-25-000938:0
● Chief Scientific & Dev. Ofc. · Executives · 13 Feb 2025
5,193 shares @ US$1.15 100.0% of flow Common Stock SEC:0000905148-25-000712:0
● Chief Financial Officer · Executives · 13 Feb 2025
8,207 shares @ US$1.15 100.0% of flow Common Stock SEC:0000905148-25-000713:0
● SVP of Corp. Dev. · Executives · 4 Feb 2025
6,751 shares @ US$1.14 100.0% of flow Common Stock SEC:0000905148-25-000401:0
● SVP of Finance · Executives · 4 Feb 2025
8,190 shares @ US$1.14 100.0% of flow Common Stock SEC:0000905148-25-000403:0
◆ Director · Executives · 2 Jan 2025
34,021 shares Common Stock SEC:0000905148-25-000038:0
◆ Director · Executives · 2 Jan 2025
50,222 shares Common Stock SEC:0000905148-25-000039:0
▲ Chief Executive Officer · Executives · 26 Dec 2024
100,000 shares @ US$0.976 42.5% of flow Common Stock SEC:0000905148-24-003425:0
Ideal exit: 22 Sept 2025 (T+270) ◆ Chief Executive Officer · Executives · 23 Dec 2024
6,200 shares 0Common Stock SEC:0000905148-24-003406:0
▲ President · Executives · 21 Nov 2024
10,000 shares @ US$0.9834 100.0% of flow Common Stock SEC:0000905148-24-003268:0
Ideal exit: 18 Aug 2025 (T+270) 25 of 29 declarations
Load more (4 remaining)